GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: May 21, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on May 21, 2025, that it purchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount involved in these transactions.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine disclosure of share repurchases, which is common for publicly traded companies.
Key Players & Entities
- GSK plc (company) — The company making the announcement and purchasing shares.
- Citigroup Global Markets Limited (company) — The corporate stockbroker acting on behalf of GSK plc for the share purchases.
- May 21, 2025 (date) — The date of the announcement and the period for which the share transactions are reported.
FAQ
What was the total number of GSK plc ordinary shares purchased?
The filing states that GSK plc purchased 'the following number of the Company's ordinary shares' but does not specify the exact quantity.
What was the total dollar amount spent on the share repurchases?
The filing does not disclose the total dollar amount spent on the purchased shares.
On what date were these share purchases made?
The filing indicates the purchases were made on 'Date of purchase: 20', implying a specific date within the reporting period, but the exact date is truncated in the provided text.
Who acted as GSK's stockbroker for these transactions?
Citigroup Global Markets Limited acted as GSK plc's corporate stockbroker for these transactions.
What is the nominal value of GSK plc's ordinary shares?
The ordinary shares are stated to be of '31¼ pence each'.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 21, 2025 regarding GSK plc (GLAXF).